Author: Hussain, Musaddique; Xu, Chengyun; Ahmad, Mashaal; Majeed, Abdul; Lu, Meiping; Wu, Xiling; Tang, Lanfang; Wu, Ximei
Title: Acute Respiratory Distress Syndrome: Benchâ€toâ€Bedside Approaches to Improve Drug Development Cord-id: wbw6dnu0 Document date: 2018_2_27
ID: wbw6dnu0
Snippet: Despite 50 years of extensive research, no definite drug is currently available to treat acute respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of treatment. To improve drug development for ARDS, researchers need to deeply analyze the “omics†approaches, reevaluate the suitable therapeutic targets, resolve the problems of inadequate animal modeling, develop the strategies to reduce the heterogeneity, and reconsider new therapeutic and analytical approach
Document: Despite 50 years of extensive research, no definite drug is currently available to treat acute respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of treatment. To improve drug development for ARDS, researchers need to deeply analyze the “omics†approaches, reevaluate the suitable therapeutic targets, resolve the problems of inadequate animal modeling, develop the strategies to reduce the heterogeneity, and reconsider new therapeutic and analytical approaches for better designs of clinical trials.
Search related documents:
Co phrase search for related documents- abnormal accumulation and acute injury: 1
- abnormal accumulation and adaptive immunity: 1
- abnormal accumulation and adaptive innate: 1
- abnormal accumulation and lps stimulation: 1
- abnormal accumulation and lung inflammation: 1
- abnormal accumulation and lung injury: 1
Co phrase search for related documents, hyperlinks ordered by date